                               SEQUENCE LISTING

<110> GENERVON BIOPHARMACEUTICALS, LLC
 
<120> METHODS OF USING GM604 IN MODULATING ALS DISEASE BIOMARKERS 
      LEADING TO PROGNOSIS AND THERAPEUTIC TREATMENT FOR ALS DISEASE

<130> GNV-010-PCT

<140> PCT/US2016/039007
<141> 2016-06-23

<150> 62/185,278
<151> 2015-06-26

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Leu Gly Thr Phe Trp Gly Asp Thr Leu Asn Cys Trp Met Leu Ser Ala 
1               5                   10                  15      


Phe Ser Arg Tyr Ala Arg Cys Leu Ala Glu Gly His Asp Gly Pro Thr 
            20                  25                  30          


Gln 
    


<210> 2
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Phe Ser Arg Tyr Ala Arg 
1               5       


<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Trp Met Leu Ser Ala Phe Ser 
1               5           


